Skip to main navigation Skip to search Skip to main content

Resistance to topoisomerase IIalfa inhibitor chremotherapy is acquired through topoIIalfa deletions and mutations

Research output: Chapter in Book/Report/Conference proceedingConference contributionScientificpeer-review

Original languageEnglish
Title of host publicationThe First Euroconference on Quantitative Molecular Cytogenetics
Pages39-
Publication statusPublished - 2000
Publication typeA4 Article in conference proceedings

Cite this